2016 Annual Meeting

College of American Pathologists

Room CC 602-604, March 13 2016, 8:30am to 12:00pm

Description

College of American Pathologists

Molecular Testing in Everyday Pathology Practice: Evolving Evidence-Based Guidelines In the Workup of Common Neoplasms

Sunday, March 13, 2016
8:30 AM 12:00 PM
CC 602 604

Moderator: Robert M. Najarian, MD, Beth Israel Deaconess Medical Center, Boston, MA
Jennifer Laudadio MD, University of Arkansas for Medical Sciences, Little Rock, AR

Course Descriptions:
The Curriculum Committee of the College of American Pathologists considers the list of past offerings, the current and evolving state of anatomic pathology, priority learning needs of pathologists, and expert opinion in selecting the topic for the 2016 CAP Companion Society education symposium.
Molecular oncology testing is rapidly evolving and changing the landscape of diagnostic medicine and the practice of pathology. Given this rapid evolution, the practicing pathologist may find it challenging to navigate the landscape of what molecular tests are essential from a patient prognostic and treatment perspective versus those that are more experimental or esoteric.
Experts at the CAP and partner organizations identified a need for evidence based practice guidelines related to molecular testing. The CAP Pathology and Laboratory Quality Center (CAP Center), along with our professional partners, advance the practice of pathology and laboratory medicine by bringing evidence-based guidelines, and consensus recommendations to the forefront of clinical decision making, including many recently published or active evolving guidelines on molecular testing of tumors. These guidelines help pathologists and clinicians make more informed decisions about diagnosis and optimal treatment, and place emphasis on the pathologist’s role at the center of patient care.Adopting these guidelines helps pathologists and laboratory professionals to provide more effective testing, consistent and high-quality results, and expert interpretations. The CAP Center develops evidence-based guidelines by following the Institute of Medicine's Standards for Developing Trustworthy Clinical Practice Guidelines to ensure a transparent and unbiased approach.

Upon completion of this educational activity, participants should be better able to:

  1. Describe the Institute of Medicine standards for developing evidence based guidelines.
  2. Identify and apply existing evidence-based guidelines in the work-up of common neoplastic entities.
  3. Discuss upcoming guidelines that can be applied in future practice.

Agenda

8:30 AM

Introduction
Robert M. Najarian, MD, Beth Israel Deaconess Medical Center, Boston, MA
Jennifer Laudadia, MD, University of Arkansas for Medical Sciences, Little Rock, AR

8:50 AM

HPV Testing in Head and Neck Carcinomas
William Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA

9:20 AM

HER2 Testing Guidelines for Adenocarcinomas of the Stomach and Gastroesophageal Junction
Angela N. Bartley, MD, St. Joseph Mercy Hospital, Ann Arbor, MI

9:50 AM

Break

10:10 AM

Recommendations for Human Epidermal Growth Factor 2 Testing in Breast Cancer
M. Elizabeth Hammond, MD, LDS Hospital, Salt Lake City, UT

10:40 AM

Revision of the CAP/IASLC/AMP Molecular Testing Guideline for Lung Cancer Biomarkers
Philip T. Cagle, MD, Houston Methodist Hospital, Houston, TX

11:10 AM

Molecular Markers for the Evaluation of Colorectal Cancer
Stanley R. Hamilton, MD, MD Anderson Cancer Center, Houston, TX

Meetings

home-circle-inset-1
view more